Your browser doesn't support javascript.
loading
Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons With Treated HIV Infection.
Graham, Susan M; Nance, Robin M; Chen, Junmei; Wurfel, Mark M; Hunt, Peter W; Heckbert, Susan R; Budoff, Matthew J; Moore, Richard D; Jacobson, Jeffrey M; Martin, Jeffrey N; Crane, Heidi M; López, José A; Liles, W Conrad.
Afiliación
  • Graham SM; Departments of Global Health.
  • Nance RM; Medicine; and.
  • Chen J; Epidemiology, University of Washington, Seattle, WA.
  • Wurfel MM; Medicine; and.
  • Hunt PW; Bloodworks Northwest Research Institute, Seattle, WA.
  • Heckbert SR; Medicine; and.
  • Budoff MJ; Department of Medicine, University of California at San Francisco, San Francisco, CA.
  • Moore RD; Epidemiology, University of Washington, Seattle, WA.
  • Jacobson JM; Department of Medicine, University of California at Los Angeles, Los Angeles, CA.
  • Martin JN; Department of Medicine, Johns Hopkins, Baltimore, MD.
  • Crane HM; Department of Medicine, Case Western Reserve University, Cleveland, OH.
  • López JA; Departments of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA.
  • Liles WC; Medicine; and.
J Acquir Immune Defic Syndr ; 93(4): 282-291, 2023 08 01.
Article en En | MEDLINE | ID: mdl-37018921
BACKGROUND: HIV infection leads to endothelial activation, promoting platelet adhesion, and accelerating atherosclerosis. Our goal was to determine whether biomarkers of endothelial activation and hemostasis/thrombosis were elevated in people with treated HIV (PWH) before myocardial infarction (MI). METHODS: In a case-control study nested within the CFAR Network of Integrated Clinical Systems (CNICS) cohort, we compared 69 adjudicated cases with type 1 MI with 138 controls matched for antiretroviral therapy regimen. We measured angiopoietin-1, angiopoietin-2 (ANG-2), intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13), von Willebrand factor, C-reactive protein (CRP), interleukin-6 (IL-6), plasminogen activation inhibitor-1, P-selectin, serum amyloid-A, soluble CD14, and apolipoprotein A1 in stored plasma. Conditional logistic regression identified associations with subsequent MI, with and without adjustment for Atherosclerotic Cardiovascular Disease (ASCVD) and Veterans Aging Cohort Study (VACS) scores. RESULTS: Higher IL-6 was associated with MI after adjustment for ASCVD score (adjusted odds ratio [AOR] 1.51, 95% confidence interval [95% CI]: 1.05 to 2.17 per standard-deviation-scaled log 2 increment). In a separate model adjusting for VACS score, higher ANG-2 (AOR 1.49, 95% CI: 1.04 to 2.14), higher CRP (AOR 1.45, 95% CI: 1.06 to 2.00), and higher IL-6 (AOR 1.68, 95% CI: 1.17 to 2.41) were associated with MI. In a sensitivity analysis excluding PWH with viral load ≥400 copies/mL, higher IL-6 remained associated with MI after adjustment for ASCVD score and after adjustment for VACS score. CONCLUSIONS: Among PWH, higher levels of plasma IL-6, CRP, and ANG-2 predict subsequent type 1 MI, independent of conventional risk scores. IL-6 had the most consistent associations with type 1 MI, regardless of viral load suppression.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Aterosclerosis / Infarto del Miocardio Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Aterosclerosis / Infarto del Miocardio Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article